As provider incentives move inexorably toward risk- and value-based reimbursement, larger provider groups are implementing standardized, clinically validated treatment pathways that often include a pharmaceutical intervention. From pharma’s perspective, the process of planning for this evolution includes:
- Understanding the objectives of the provider office
- Establishing a value proposition for the brand that is aligned with the provider’s objectives within the context of an evidence-based clinical pathway that is supported by credible, authoritative guidelines and specific patient profiles
- Building pathways that support the use of the brand
- Using analytics to demonstrate brand value based on outcomes
Because these pathways are being embedded within the technology infrastructure of large organizational customers, they are among the most effective ways to secure and safeguard brand preference. Conversely, those who fail to adapt to pathways risk the brand being locked out or left behind.
At Aventria Health Group, we can help you equip and support your key organizational customers to drive your brand utilization. To learn more about how our expertise can help you, click below for additional information.